JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
Description: Semagacestat (also known as LY450139; LY4501) is a novel and potent gamma-secretase inhibitor/blocker for Abeta42, Abeta40 and Abeta38 with the potential for treating Alzheimer's disease. It inhibits Abeta42, Abeta40 and Abeta38 with IC50 calues of 10.9 nM, 12.1 nM and 12.0 nM, it also inhibits Notch signaling with IC50 of 14.1 nM in H4 human glioma cell. Semagacestat was in Phase III trials, but was terminated in August 2010, due to a disppointing performance.
References: J Neurosci. 2012 Feb 8; 32(6):2037-50; J Neurochem. 2009 Sep; 110(5):1377-87.
Chemical Name: (S)-2-hydroxy-3-methyl-N-((S)-1-(((S)-3-methyl-2-oxo-2, 3, 4, 5-tetrahydro-1H-benzo[d]azepin-1-yl)amino)-1-oxopropan-2-yl)butanamide
SMILES Code: CC(C)[CH](O)C(N[CH](C)C(N[CH]1C(N(C)CCC2=CC=CC=C12)=O)=O)=O
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.
Request Data Sheet
Request product datasheet
Request safety datasheet
Compare
Add to wishlist
Recommend by mail
Get an offer
Request delivery time
Ask a technical question
Submit a bulk request
sales@hoelzel.de
« Back
Subscribe, get 15% off every fifth order and have your items delivered on time!
Forgot Your Password?
Not yet registered? Create account here!